Stay updated on ABP 798 vs. Rituximab in RA Clinical Trial
Sign up to get notified when there's something new on the ABP 798 vs. Rituximab in RA Clinical Trial page.

Latest updates to the ABP 798 vs. Rituximab in RA Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site version, v3.6.6, has been released, replacing the previous v3.6.5.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe revision tag on the page was updated from Revision: v3.6.4 to Revision: v3.6.5, reflecting a newer release version.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page's revision metadata was updated from v3.6.3 to v3.6.4, indicating a new version of the page without altering displayed information.SummaryDifference0.0%

- Check70 days agoChange DetectedThe revision label on the page was updated from v3.6.2 to v3.6.3, indicating a new release. This reflects an update to the document versioning rather than substantive content changes.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a newer document version without changes to the main content.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page now indicates that recruitment is closed and adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the Intervention/Treatment heading formatting and the revision label to Revision: v3.6.0.SummaryDifference0.3%

Stay in the know with updates to ABP 798 vs. Rituximab in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 798 vs. Rituximab in RA Clinical Trial page.